Inventiva S.A.
IVA • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$171.02M
Growth
-19.1%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 3.15Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Sep 30, 2026, 12:07 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$171.02M
52W Range3.10 - 7.98
Beta0.91
Gross Margin33.68%
Oper. Margin-29.21%
Profit Margin-75.88%
Debt/Eq-2.05
Current Ratio3.15
Quick Ratio3.15
Revenue 5Y-19.10%
Price$0.00
Change0.00%
Market Cap$171.02M
52W Range3.10 - 7.98
Beta0.91
Gross Margin33.68%
Oper. Margin-29.21%
Profit Margin-75.88%
Debt/Eq-2.05
Current Ratio3.15
Quick Ratio3.15
Revenue 5Y-19.10%
Target$14.00
Target Median$14.00
Target Range14.00 - 14.00
Volume3.83M
Avg Volume1.20M
EPS Surprise-0.84
Investment DNA
How strong this company looks for long-term investors
28
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 3.15Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-09-30
Low
$14.00
Mean
$14.00
Median
$14.00
High
$14.00
🧾
No insider activity
No recent insider transactions available.